Literature DB >> 8052955

High incidence of thrombophilia detected in Chinese patients with venous thrombosis.

H W Liu1, Y L Kwong, C Bourke, C K Lam, A K Lie, D Wei, L C Chan.   

Abstract

Venous thromboembolism is rare in Chinese. To determine the incidence and disease profile of thrombophilia in Chinese patients with thrombosis, 52 unselected Chinese patients with documented venous thrombosis were studied for the presence of thrombophilia. Levels of antithrombin III (AT III), protein C (PC) and protein S (PS) as well as the presence of acquired lupus anticoagulant (LA) and anticardiolipin antibody (ACA) were investigated. Thirty patients were found to be abnormal. These consisted of 5 AT III deficiencies, 9 PC deficiencies, 10 PS deficiencies, 1 combined PC & PS deficiency (all in the heterozygous range), and 5 patients with LA and/or ACA. When the patients with LA and/or ACA are excluded, the incidence of hereditary thrombophilia is 25/47 i.e. 53.2% which is much higher than those reported in studies of Caucasian patients selected under strict criteria. Family studies performed in 16 cases of hereditary thrombophilia revealed involvement in 11 cases (68.7%); a total of 36 heterozygous family members were affected, most of which remain asymptomatic. Although 35 events predisposing to thrombosis (27 pregnancies, 1 oral contraceptive consumption and 7 surgical operations) were identified among these index patients, and the heterozygous family members, thrombosis was observed on only 6 occasions (17.1%). The data suggest that pregnancy and surgery do not carry the same degree of thrombotic risk in Chinese as in the Caucasian population with heterozygous AT III, PC and PS deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052955

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

Review 2.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

3.  Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism.

Authors:  Yu-Dong Yin; Chen Wang; Zhen-Guo Zhai; Bao-Sen Pang; Yuan-Hua Yang; Xiu-Xia Huang
Journal:  J Thromb Thrombolysis       Date:  2008-03-31       Impact factor: 2.300

4.  Rare double heterozygous mutations in antithrombin underlie hereditary thrombophilia in a Chinese family.

Authors:  Haoyu Deng; Jiaquan Chen; Hui Xie; Yi Gu; Kai Yuan; Peng Wang; Wei Shen; Wei Liang; Hao Zhang; Jiwei Zhang; Jun Xie; Lan Zhang
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

5.  Association of SERPINC1 Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population.

Authors:  Yongjian Yue; Qing Sun; Lu Xiao; Shengguo Liu; Qijun Huang; Minlian Wang; Mei Huo; Mo Yang; Yingyun Fu
Journal:  Front Genet       Date:  2019-09-13       Impact factor: 4.599

Review 6.  Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.

Authors:  Naotaka Hamasaki; Hiroyuki Kuma; Hiroko Tsuda
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.